Personalizing medicine for autoimmune and inflammatory diseases
- PMID: 23334822
- DOI: 10.1038/ni.2473
Personalizing medicine for autoimmune and inflammatory diseases
Abstract
Therapies that target molecular pathways do not provide uniform benefits for all patients at present. New transformative therapies for autoimmune and inflammatory diseases require greater molecular understanding of patient subsets and the ability to personalize targeted therapies for each subset.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical